LG
PRCT icon

Lane Generational’s Procept Biorobotics PRCT Stock Holding History

Lane Generational’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
78,422
-24,760
-24% -$620K 1.55% 23
2026
Q1 		$2.58M Buy
103,182
+46,358
+82% +$1.31M 2.05% 21
2025
Q4 		$1.79M Buy
+56,824
New +$1.88M 1.62% 22

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lane Generational's PRCT Position: Q2 2026 in Review

Lane Generational reduced its Procept Biorobotics (PRCT) stake by 24% in Q2 2026, selling an estimated $620K and leaving 78,422 shares worth $1.77M. The position accounts for 1.55% of the portfolio, ranked #23.

Lane Generational first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.58M in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Lane Generational held 78,422 shares of Procept Biorobotics worth $1.77M as of Q2 2026.
  • Lane Generational sold 24,760 Procept Biorobotics shares in Q2 2026, an estimated $620K.
  • Procept Biorobotics made up 1.55% of Lane Generational's portfolio in Q2 2026, its #23 holding.
  • Lane Generational first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • Lane Generational's Procept Biorobotics position peaked at $2.58M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Lane Generational's 13F filing for Q2 2026, filed 13 Aug 2026.